This new test gives a less-invasive option to aid in diagnosis and makes it more available because patients will not have to wait for a neurologist to start the process. The FDA warns that blood tests ...

The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...

The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.

The Food and Drug Administration has approved the first blood test for diagnosing Alzheimer's disease, the agency announced ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...

Affordable rapid diagnostics are key to ensuring that sick patients get the right treatment, but also that antibiotics are not applied unnecessarily – a practice that is contributing to the much ...

In this environment, diagnostics and testing appear comparatively safer, and companies like GeneDx and Natera, Inc. (NTRA), another Prudent Healthcare model portfolio holding, appear to be better ...

US & Canada, April 28, 2025 (GLOBE NEWSWIRE) -- As per a new, comprehensive report from The Insight Partners, the Point of Care Diagnostics Market is experiencing significant growth owing to ...

This investment in TB diagnostics aligns with GHIT’s broader mission to address diseases affecting vulnerable populations. Last December, Fujirebio and Eisai signed a memorandum of understanding for ...

"With advances in experimental diagnostics, technology and computing, we are now at a point where we can understand it because we have these new tools," Khare said. But there is still much to explore.

Inc., 4 in partnership with Fujirebio, Inc., a developer of clinical diagnostics in Japan, 4 and Heidelberg University Hospital in Germany. This project will leverage Fluxus' cutting-edge ...